Continue reading this on our app for a better experience

Open in App
Floating Button

Livingstone shares close at 12.5% premium above price of new consolidation shares on Catalist board

Felicia Tan
Felicia Tan • 2 min read
Livingstone shares close at 12.5% premium above price of new consolidation shares on Catalist board
The listing is the first on SGX for 2021, and marks a new chapter of the Singapore-based multidisciplinary healthcare specialist.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Shares in Livingstone Health Holdings closed at 22.5 cents, representing a 12.5% premium above the 20 cents that was priced in for its post-consolidation shares on Feb 8.

The shares were issued as part of the reverse merger of the former Citicode.

The listing is the first on SGX for 2021, and marks a new chapter of the Singapore-based multidisciplinary healthcare specialist.

Shareholders in Citicode approved the reverse takeover (RTO) on Jan 22, which involved a 500-to-1 consolidation of the share base from 41.3 billion to 82.6 million shares, and a transfer of listing status to the Catalist board from the Mainboard.


SEE:Citicode shareholders approve RTO of Livingstone Health, trading suspension to begin Feb 2

Upon completion of the RTO, Livingstone’s share base has been enlarged to 315.9 million shares from 82.6 million shares.

See also: Singtel to sell mobile wallet Dash to Western Union Testing QA

Dr Wilson Tay, executive director and CEO of Livingstone Health, says: “The completion of the RTO and the first-day trading mark a major new chapter in the growth of the Group. We intend to leverage on our capital markets platform to accelerate growth and deepen our value proposition as an integrated healthcare provider in Singapore and the region.”

“On behalf of the board of directors I thank SGX, the management team, the professionals, the shareholders and the many people whose hard work, patience and support have culminated in today’s first-day trading on Catalist,” he adds.

Mohamed Nasser Ismail, Global Head of Equity Capital Markets, SGX, says: “We are pleased to welcome the listing of homegrown Livingstone Health Holdings Limited on SGX Catalist. With Singapore’s healthcare industry recognised as among the best in the world, together with SGX’s connectivity in the region, we look forward to supporting Livingstone Health in its efforts to tap on the rising growth opportunities in Asia.”

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.